Alnylam and Stanford University Scientists Discover New Role for
microRNAs (miRNAs) in T Cell Biology and Immunity
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar 22, 2007 - Alnylam
Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics
company, announced today publication of a study in the journal Cell
by Alnylam and
Stanford University scientists on the role of miRNAs
in immunity. In the pre-clinical study,...
Limiting Eligibility for Medical Studies Can Omit Women,
African-Americans, Stanford Study Finds
STANFORD, Calif.--(BUSINESS WIRE)--May 24, 2007 - A new analysis
has found that many alcohol treatment studies are designed in ways
that inadvertently omit women and African-Americans from
participation. The
Stanford University School of Medicine
researcher who led the effort said the findings shou...
Common Preterm Labor Drug Has More Side Effects Than Alternative,
Finds Study from Packard Children's Hospital and Stanford
STANFORD, Calif.--(BUSINESS WIRE)--Jun 29, 2007 - The drug most
commonly used to arrest preterm labor, magnesium sulfate, is more
likely than another common treatment to cause mild to serious side
effects in pregnant women, according to a study from researchers at
Lucile Packard Children's Hospital...
Scientists Discover Origin of Malaria
... mosquitoes.
An international group of researchers, including senior author Nathan Wolfe, Ph.D., of the Global Viral Forecasting Initiative and
stanford University, made the discovery, published in the Aug. 3 2009 Proceedings of the National Academy of Sciences, by identifying several new parasites f...
Neurobiological Technologies' Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical Program
...ects in the treatment of patients with brain tumors is an important goal," said Lawrence Recht, MD, Professor of Neurology and Neurological Sciences,
stanford University Medical Center. "The results of these late-stage studies are encouraging, both in terms of lowering dexamethasone use over the longer-term...
Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma
...of
Medicine and Co-Chief of the Division of Immunology and Rheumatology at
stanford University Medical Center and member of Pharmacyclics' Scientific
Advisory... of
PCI-32765 in patients with refractory B-cell non-Hodgkin's lymphoma at
stanford University , MD Anderson Cancer Center and the University of Chicago
usin...
PEAK Surgical Announces Completion of First PRECISE Clinical Study, Receipt of Medical Design Excellence Award for PEAK(R) Surgery System and Achievement of Over 1,000 Surgeries Using PEAK PlasmaBlade(TM)
...charges and electrode insulation techniques were originally invented at the Hansen Experimental Physics Laboratory and Department of Ophthalmology at
stanford University and developed by PEAK Surgical.
About PEAK Surgical, Inc.
PEAK Surgical, Inc. is a medical device company that has developed the ...
CyberKnife Radiosurgery for Lung Cancer Sees Increased Interest and Continued Rapid Growth
...and involvement with CyberKnife radiosurgery. Dr. Luketich's points were further underscored by Richard Whyte, M.D., Professor of Thoracic Surgery at
stanford University School of Medicine. During his STS University session, Dr. Whyte reviewed the importance of the CyberKnife System as a tool available to t...
Global Health Research Foundation Awarded $25,000 Grant From Westly Foundation to Study Asthma in California's Central Valley
...used in a study of children's asthma and pollution levels conducted by the
stanford University School of Medicine. "Asthma cases have more than doubled in th...ect undertaken by Dr. Kari Nadeau, an assistant professor of pediatrics at
stanford University and Lucile Packard Children's Hospital. The project plans to a...
Medgenics Announces Positive Data From Phase I/II Clinical Trial of EPODURE Treatment of Anemia in Chronic Kidney Disease
...rd to seeing EPODURE's performance in the next group of patients who will be receiving higher doses."
Professor Eugene Bauer, MD, Dean Emeritus,
stanford University School of Medicine and Chairman of Medgenics commented:
"This is a groundbreaking study. These continuing results demonstrate that ...
PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications
...harges and electrode insulation techniques
were originally developed at the Hansen Experimental Physics Laboratory and
Department of Ophthalmology at
stanford University .
About PEAK Surgical, Inc.
PEAK Surgical, Inc. is a medical device company that has developed the
PEAK(R) Surgery System, ...
Delcath Adds Dr. Pamela R. Contag to Its Board of Directors
...ty of Minnesota Medical School and completed her postdoctoral training at
stanford University School of Medicine. Dr. Contag is a consulting Professor at the
stanford School of Medicine and is widely published in the field of non-invasive mol...
ACTEMRA (R) (tocilizumab) Significantly Reduced Signs and Symptoms of Rheumatoid Arthritis in Patients Who Failed Prior Treatments
...ting therapies, many patients with RA
continue to experience symptoms of joint pain and stiffness," said Mark
Genovese, M.D., Professor of Medicine at
stanford University School of
Medicine. "The compelling results of these studies further support the
efficacy and safety of ACTEMRA as a potential new treatmen...
Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings
...ize
Intermezzo(R)."
Middle of the Night Awakenings & Intermezzo(R)
According to a recent independent study, conducted by Dr. Maurice
Ohayon of the
stanford Sleep Epidemiology Research Center, middle of the
night awakening is the most frequently reported insomnia symptom. This
study estimates that 35% of A...
PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) Needle
...charges and electrode insulation
techniques were originally developed at the Hansen Experimental Physics
Laboratory and Department of Ophthalmology at
stanford University.
PEAK Surgical is exploring the applicability of its technology across
numerous surgical fields beyond general surgery, including cardiot...
Prescription Sleeping Pill Use Tied to Cancer
... cancer, has just been published in the Journal
of Sleep Research. It appears with an editorial authored by Dr. Gary D.
Friedman, an epidemiologist at
stanford University's School of Medicine and
adjunct investigator at the Kaiser Permanente Medical Care Program who has
vast experience in investigating the ca...
The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer
... Health Organization, Fact Sheet N degree 164, October 2000. http://www.who.int/mediacentre/factsheets/fs164/en/ . Accessed May 2008. (4)
stanford University School of Medicine, Asian Liver Center, "FAQ About Hepatitis B," February 2008. http://liver.stanford.edu/Education/faq.html . ...
Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications
...ting in NeuRx DPS(TM) clinical
testing for ALS:
-- University Hospitals Case Medical Center, Cleveland, Ohio -- Johns Hopkins, Baltimore, Md. --
stanford University, Stanford, Calif. -- Methodist Neurological Institute, Houston, Texas -- Henry Ford Health System, Detroit, Mich. -- Mayo Clinic, Jackso...
Genetic Engineering & Biotechnology News Reports on the Growing Role of Ion-Channel Studies in Global Biotech R&D
...itor in
Chief of GEN.
On the basic research side, Merritt Maduke, PhD, assistant professor in
the department of molecular and cellular physiology at
stanford University
School of Medicine, has built a lab focused on elucidating the molecular
mechanisms underlying the function of the CLC chloride channels, t...
Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study
...d Health Organization, Fact Sheet N degree 164, October 2000. http://www.who.int/mediacentre/factsheets/fs164/en/ . Accessed May 2008. (4)
stanford University School of Medicine, Asian Liver Center, "FAQ About Hepatitis B," February 2008. http://liver.stanford.edu/Education/faq.html . A...
PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) for Obstetric and Gynecologic Surgery
...enthal, M.P.H., professor in the Department of
Obstetrics and Gynecology at
stanford University School of Medicine.
"The findings of this comparative preclini...e Hansen Experimental
Physics Laboratory and Department of Ophthalmology at
stanford University.
Because the radiofrequency is provided in short on-and-off puls...
Caliper Life Sciences' Optical Imaging Technology Selected to Aid Tuberculosis Research Efforts by the Texas A&M Health Science Center
...searchers at the Texas A&M Health Science Center College of Medicine
and a consortium of leading tuberculosis researchers at Washington
University and
stanford University School of Medicine are actively studying
tuberculosis infections in live animals using in vivo imaging technology.
Caliper's IVIS Spectrum ...
Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
...rimary liver cancer and hepatitis. In
neurodegenerative diseases, engineered RAP peptides called NeuroTrans(TM)
are currently undergoing evaluation at
stanford University in cell culture
and preclinical models for their ability to enhance the transport of
molecules from blood to brain. In an effort to protect...
Data Presented at the American Academy of Neurology Show XP13512/GSK1838262 Significantly Improved Symptoms of Moderate-to-Severe Primary Restless Legs Syndrome
...minergic agent to demonstrate
efficacy in treating the symptoms of RLS in large controlled clinical
trials," said Clete Kushida, M.D., director of the
stanford Center for
Human Sleep Research and a clinical investigator in the PIVOT RLS I
clinical trial.
Additional data presented at the meeting compared the...
Recent Studies Suggest Popular 'Diet Pill' Relacore Reduces Acne Breakouts
... Feb. 15 /PRNewswire/ -- As crazy as it sounds, recent studies
conducted at
stanford and Wake Forest Schools of Medicine suggest there's a
connection between st...mination Stress," Archives of Dermatology (2003) Department
of Dermatology,
stanford School of Medicine)
So if you're looking for America's newest and most su...
Fundamental Applied Biology, Inc. Is Awarded SBIR Phase IIB Grant for the Commercialization of Protein Therapeutics Using Cell Free Technology
...research initiatives to develop marketable
biologics as a continuation of work initiated in my laboratory at the
Department of Chemical Engineering at
stanford University," noted Professor
James Swartz, D.Sc.
Intact organisms which have the limitation of having to maintain their
own viability can have diffi...
Study of Pathwork Diagnostics' Tissue of Origin Test Published in the Journal of Molecular Diagnostics: Investigates Test Reproducibility in Multiple Labs to Determine Primary Tumor in Cancer Cases
..., performed by principal
investigator Federico A. Monzon, M.D., and colleagues from the University
of Pittsburgh, Virginia Commonwealth University and
stanford University,
examined the analytical performance characteristics and reproducibility of
the Tissue of Origin Test.
There are an estimated 200,000 can...
New Conflict of Interest Violations Revealed at California Stem Cell Institute
... all those who acted correctly. For instance,
Dr. Philip Pizzo, dean of the
stanford University School of Medicine, told
the Chronicle: "I can only say that as ...ust recuse myself from any grant
application, proposal or action related to
stanford or any other individual
or setting where I could have a conflict of interes...
Two Pivotal Phase III Studies for Roche's ACTEMRA(TM) (tocilizumab) Demonstrate Significant Improvement in Rheumatoid Arthritis Symptoms
...
symptoms compared with DMARDs alone," said Mark C. Genovese, M.D., lead
study investigator of the TOWARD trial and Associate Professor of Medicine
at
stanford University School of Medicine. "The data from both studies
further establish the efficacy of ACTEMRA and confirm that inhibiting
interleukin-6 (IL-6) ...
VIA Pharmaceuticals Presents Data at American Heart Association Meeting Showing VIA-2291 Significantly Reduces Inflammation in Preclinical Model of Atherosclerosis
...lly modified to develop
atherosclerosis. A team of researchers headed by Thomas Quertermous, M.D.,
chief of the Division of Cardiovascular Medicine at
stanford University,
and chief scientific officer of VIA Pharmaceuticals, demonstrated a
significant decline in the extent of atherosclerosis detected after a ...
Synvista Therapeutics' Alagebrium Shows Potential for use in Treating Diabetes-Related Gastrointestinal Complications
...etic patients in the U.S.
and many more worldwide. Pankaj J. Pasricha, M.D., Ph.D., Professor and Chief, Division of
Gastroenterology & Hepatology at
stanford University School of Medicine,
and colleagues; Dr. Prince VS Jeyabal, Dr. Raj Kumar, Dr. Pandu RR Gangula,
Dr. Mary-Adelaide Micci; from the Universit...
Raptor Pharmaceuticals Provides Update of Product Programs
... and reduce
the amount of powerful antiviral agents elsewhere in the body.
stanford University Grant Renewed for NeuroTrans(TM) in
Neurodegenerative Diseases ...d RAP peptides called
NeuroTrans(TM) are currently undergoing evaluation at
stanford University
in cell culture and preclinical models for their ability to enha...
Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
...ed in collaboration with
the Division of Gastroenterology and Hepatology at
stanford University
School of Medicine by Emmet B. Keeffe, M.D., Jeffrey S. Glenn, M.D., Ph.D.
and Dr. Rossignol who is also a
stanford affiliate. Nitazoxanide is the first of a new class of small molecule drug...
Study of Drug Therapy for Compulsive Buying Yields a Puzzle,
Stanford Researcher Says
...(BUSINESS WIRE)--Mar 14, 2007 - Researchers at
the
stanford University School of Medicine say they are puzzled... and Emily Smith, clinical research
coordinator.
stanford University Medical Center integrates research, med...tutions -- Stanford
University School of Medicine,
stanford Hospital & Clinics and
Lucile Packard Children...
Stanford Study Finds No Conclusive Benefit From Treating
Kleptomania With Medication
...stealing
disorder, according to researchers at the
stanford University
School of Medicine.
But the results le...arch manager, was also a co-author on the study.
stanford University Medical Center integrates research, med...tutions -- Stanford
University School of Medicine,
stanford Hospital & Clinics and
Lucile Packard Children...
Presentations at American College of Cardiology Meeting Highlight
New Opportunities for HDL Therapy
...Research
Institute at the Washington Hospital Center by Dr. Neil Weissman,
Director of the Cardiac Ultrasound and Ultrasound Core
Laboratories, and at
stanford University Medical Center by Dr.
Peter J. Fitzgerald, Director of the Center for Research in
Cardiovascular Interventions and the Cardiovascular Core ...
Avalon Pharmaceuticals to Present at the American Association for
Cancer Research 2007 Annual Meeting
...ril 17, 2007 from 8 a.m. until noon Pacific Time.
Another poster that will discuss AVN944 will be presented by the
lab of Dr. Beverly Mitchell of
stanford University. The poster is
titled, "GTP depletion induces translocation of TIF-IA and PAF53,
inhibition of pre-rRNA synthesis and dislocation of nucleo...
Fragile X, Down Syndromes Linked to Faulty Brain Communication,
Stanford Researcher Finds
...th
and Stanford's Down Syndrome Research Center.
stanford University Medical Center integrates research, med...tutions -- Stanford
University School of Medicine,
stanford Hospital & Clinics and
Lucile Packard Children...ffairs at
http://mednews.stanford.edu.
Contact
stanford University Medical Center
Krista Conger, 650-725-...
Cellerant Therapeutics Reversed Autoimmune Disease in Lupus Mice
with Transplant of Purified Donor Blood Stem Cells
...cedure exhibited improved overall survival and decreased lupus
symptoms. The research, led by Dr. Julie Christensen with
colleagues from Cellerant and
stanford University, was published on
April 13, 2007 as a First Edition Paper in the online version of
the American Society of Hematology's journal, BLOOD (Smi...
Once-Fatal Metabolic Disorders Treatable, Says Stanford/Packard
Researcher
...fully treated with drugs, says a
researcher at the
stanford University School of Medicine and Lucile
Packard C...ne meeting
of the advisory board of the company.
stanford University Medical Center integrates research, med...tutions -- Stanford
University School of Medicine,
stanford Hospital & Clinics and
Lucile Packard Children...